Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612] (DOI:10.1016/j.bmcl.2007.05.082);A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 16, 2007, Pages 4604-4612

  Chhabra, Sandeep ^a   Sharma, Pooja ^a   Ghoshal, Nanda ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Diospyrin; Human DNA TopI; L. donavani DNA TopI; Molecular docking; Structure based pharmacophore

Indexed keywords

AMINO ACID DERIVATIVE; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; DIOSPYRIN; DNA TOPOISOMERASE;

ANIMAL CELL; ARTICLE; CALCULATION; CATALYSIS; CORRELATION COEFFICIENT; CYTOTOXICITY; DRUG BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; LIGAND BINDING; MATHEMATICAL MODEL; NONHUMAN; STRUCTURE ACTIVITY RELATION; VALIDATION STUDY;

DAMALISCUS LUNATUS;

EID: 34447309318     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.08.001     Document Type: Erratum

References (27)

1. Jean-Moreno V., Rojas R., Goyeneche D., Coombs G.H., and Walker. J. Exp. Parasitol. 112 (2006) 21
2. Lauria A., Ippolito M., and Almerico A.M. J. Mol. Model. 13 (2006) 393
3. Ray S., Hazra B., Mittra B., Das A., and Majumdar H.K. Mol. Pharmacol. 54 (1998) 994
4. Ganapaty S., Steve T.P., Karagianis G., Waterman P.G., and Brun R. Phytochemistry 67 (2006) 1950
5. Bailly C. Curr. Med. Chem. 7 (2000) 39
6. Das S.M., Ghosh R., Patra A., Sharma P., Ghoshal N., and Hazra B. Bioorg. Med. Chem. (2006) 12 [Epub ahead of print]
7. Reguera R.M., Redondo C.M., Gutierrez de Prado R., Pérez-Pertejo Y., and Balaña-Fouce R. Biochimica. Biophysica. Acta 1759 (2006) 117
8. Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D., Stewart L., and Burgin A.B. J. Med. Chem. 48 (2005) 2336
9. Davies D.R., Mushtaq A., Interthal H., Champoux J.J., and Hol W.G. J. Mol. Biol. 357 (2006) 1202
10. MSI Cerius2 Version 4.9, Molecular simulations, Accelrys Inc., 9685 Scranton Rd., San Diego, CA 92121, USA.
11. Rappe A.K., Casewit C.J., Colwell K.S., Goddard W.A., and Skiff III W.M. J. Am. Chem. Soc. 114 (1992) 10024
12. GOLD 3.0; Cambridge Crystallographic Data Centre: Cambridge, CB2 1EZ, UK.
13. Jones G., Willett P., Glen R.C., Leach A.R., and Taylor R. J. Mol. Biol. 267 (1997) 727
14. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., and Taylor R.D. Proteins Struct. Funct. Genet. 52 (2003) 609
15. Maple J.R., Hwang M.J., Stockfish T.P., Dinur U., Waldman M., Ewig C.S., and Hagler A.T. J. Comput. Chem. 15 (1994) 161
16. Mehler E.L., and Solmajer T. Protein Eng. 4 (1991) 903
17. Leach A.R. Molecular Modelling: Principles and Applications (2001), Pearson Edu. Ltd, England 165-252 Chapter 4
18. Sharma P., and Ghoshal N. J. Chem. Inf. Model 46 (2006) 1763
19. Wolber G., and Langer T. J. Chem. Inf. Model. 45 (2005) 160
20. Stewart L., Ireton G.C., and Champoux J.J. J. Biol. Chem. 271 (1996) 7602
21. Stewart L., Ireton G.C., and Champoux J.J. J. Mol. Biol. 269 (1997) 355
22. Tazi J., Bakkour N., Soret J., Zekri L., Hazra B., Laine W., Baldeyrou B., Lansiaux A., and Bailly C. Mol. Pharmacol. 67 (2005) 1186
23. Bodley A.L., Wani M.C., Wall M.E., and Shapiro T.A. Biochem. Pharmacol. 50 (1995) 937
24. Chessman S.J. Parasitol. Today 16 (2000) 277
25. Bakshi R.P., and Shapiro T.A. Mini-Rev. Med. Chem. 3 (2003) 597
26. Muegge I., Martin Y.C., Hajduk P.J., and Fesik S.W. J. Med. Chem. 42 (1999) 2498
27. Irene N., Mitchell J.B.O., Alexander A., and Thornton J. J. Comput. Chem. 22 (2001) 673